Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

Among adults with type 2 diabetes who started noninsulin second-line therapy, most modified treatment within 1 year. Discontinuation was by far the most common modification. Objectives: To describe ...

For years, metformin has been the go-to first-line oral medication for patients newly diagnosed with type 2 diabetes. But with the growing popularity and effectiveness of medications like semaglutide ...

Please provide your email address to receive an email when new articles are posted on . The American Diabetes Association Scientific Sessions featured symposia on novel treatments for diabetes and ...

Stem cell therapy is an emerging treatment for type 2 diabetes. Although it’s not yet FDA-approved in the United States, it is a rapidly expanding and promising field of research. Stem cells are ...

Nearly 39 million American adults are currently living with diabetes, the latest data shows — and between 90% and 95% of those cases are type 2 diabetes. Type 1 diabetes, although it only makes up 5% ...

Building on earlier studies showing its benefits for type 2 diabetes, a new study has revealed the experimental drug IC7Fc may also help prevent heart disease by lowering cholesterol and reducing ...

Game-changing new medications called GLP-1 agonists and SGLT2 inhibitors can not only control blood sugar but also help people lose weight by making them feel full faster, so they eat less. Why is ...

In a recent study published in the journal eClinical Medicine, researchers performed a meta-analysis to evaluate the glucose-lowering potential of glucagon-like peptide-1 receptor agonist (GLP-1 ...

Over the past few decades, doctors have noticed a sharp increase in type 2 diabetes among Black children and teenagers. Since type 2 diabetes is showing up earlier in life, it is leading to more ...